Live Breaking News & Updates on Poster Discussion|Page 5

Stay updated with breaking news from Poster discussion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting

Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Santa Monica , Foster City , Jacquie Ross , Merdad Parsey , Nathan Kaiser , Frank Neumann , Anna Padula , Rituximab Rtx , L Axicabtagene Ciloleucel , Axicabtagene Ciloleucel , Azacitidine Monotherapy , Gilead Sciences , American Society Of Clinical Oncology , Kite Global Head Of Clinical Development , Gilead Sciences Inc , Exchange Commission , Association Of Pretreatment Pretx Tumor Characteristics , Gilead Company , Gilead Public Affairs , Diverse Hematologic Research , Heavily Pre Treated , Breast Cancer Patients , New Sub Analysis , Therapy Study , Patients Aged ,

Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") will share new research during the 2022 American Society. ....

United States , Kenji Yasukawa , Ahsan Arozullah , Enfortumab Vedotin , Erhan Berrak , Global Medical Affairs , American Society Of Clinical Oncology , European Hematology Association , Astellas Pharma Inc , Head Of Development Therapeutic Areas , Prnewswire Astellas Pharma Inc , Medivation Inc , Clinical Oncology , Annual Meeting , Senior Vice President , Development Therapeutic Areas , Vice President , Poster Discussion , Genitourinary Cancer , Discussion Session , Poster Presentation , Gastrointestinal Cancer , Focus Area Approach , Astellas Pharma Inc ,

Sapience Therapeutics Announces Poster Presentation on ST101 Phase 1 Study Results at the American Society of Clinical Oncology (ASCO) Annual Meeting 2022

/PRNewswire/ Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address. ....

United States , Barry Kappel , Amy Conrad , American Society Of Clinical Oncology , European Commission , Sapience Therapeutics Inc , Sapience Therapeutics , American Society , Clinical Oncology , Annual Meeting , Developmental Therapeutics , Molecularly Targeted Agents , Tumor Biology , Poster Discussion , Fast Track , Chief Executive , Investor Contact ,

Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA (pembrolizumab)

10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology . ....

United States , Neoadjuvant Pembrolizumab , Pembrolizumab Pembro , Pembrolizumab Monotherapy , Statement Of Merck Co Inc , Merck Co Inc , Exchange Commission , Oncology Investor Event , Oral Presentation , Exploratory Analysis , Poster Presentation , Year Follow Up Of The Phase , Health Related Quality Of Life , Impact Of Pembrolizumab , Plus Best Supportive Care , Versus Placebo , Therapy In Patients , Asia With Advanced Hepatocellular Carcinoma , For Patients With , Metastatic Urothelial Carcinoma , Are Potentially Platinum , Poster Discussion , Plus Axitinib , Expanded Efficacy Analyses From , Cohort With More Than , For Von Hippel Lindau ,

Curis Reports First Quarter 2022 Financial Results and Business Update

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today. ....

United States , Roche Erivedge , James Dentzer , American Society Of Clinical Oncology , European Hematology Association , Drug Administration , Washington University School Of Medicine , Curis Inc , American Society Of Clinical Oncology Annual Meeting , Development Expenses , Exchange Commission , Prnewswire Curis Inc , Roche Group , Washington University In St , Washington University , Chief Executive Officer , Recommended Phase , Recent Operational , Takeaim Leukemia , Washington University School , Clinical Oncology Annual , Hematologic Malignancies , Chronic Lymphocytic , Poster Discussion , Myelodysplastic Syndromes , Gastrointestinal Cancer ,